Atlas Trials

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Clinical trial NCT05000892 · RECRUITING

Trial details

NCT number
NCT05000892
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Salivary Gland Malignant NeoplasmsSalivary Gland Tumors
Start date
2021-12-10
Primary completion
2023-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.